Holen Sie sich die Stockscreener-App
5.29
0.95%
0.05
Handel nachbörslich:
5.11
-0.18
-3.40%
Schlusskurs vom Vortag:
$5.24
Offen:
$5.06
24-Stunden-Volumen:
67,600
Relative Volume:
0.31
Marktkapitalisierung:
$2.52M
Einnahmen:
$9.81M
Nettoeinkommen (Verlust:
$-26.16M
KGV:
-0.0826
EPS:
-64.04
Netto-Cashflow:
$-17.45M
1W Leistung:
-6.54%
1M Leistung:
-5.20%
6M Leistung:
-48.24%
1J Leistung:
-62.00%
1-Tages-Spanne:
$4.9505
$5.42
1-Wochen-Bereich:
$4.90
$5.89
52-Wochen-Spanne:
$4.60
$34.22
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Firmenname
Reshape Lifesciences Inc
Sektor
Branche
Telefon
949-429-6680
Adresse
1001 CALLE AMANECER, SAN CLEMENTE
Vergleichen Sie RSLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| RSLS | 5.29 | 2.52M | 9.81M | -26.16M | -17.45M | -64.04 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten
Earnings call: ReShape Lifesciences reports growth and strategic mergers - Investing.com
Earnings call: ReShape Lifesciences reports growth and strategic mergers By Investing.com - Investing.com Canada
ReShape Lifesciences Reports Q3 Growth and Strategic Moves - TipRanks
ReShape Lifesciences Inc (RSLS) Quarterly 10-Q Report - Quartzy
ReShape Lifesciences® Reports Third Quarter Ended September - GlobeNewswire
ReShape Lifesciences Reports 16.6% Revenue Growth, Inks $5.16M Asset Sale Deal | RSLS Stock News - StockTitan
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update - The Manila Times
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and - The Bakersfield Californian
Gastric Electrical Stimulators Market Size, Share and Growth - openPR
Health Canada approves ReShape's Lap-Band 2.0 FLEX By Investing.com - Investing.com Australia
ReShape Lifesciences® to Announce Financial Results for the - GlobeNewswire
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - The Manila Times
FibroGen Reports Third Quarter 2024 Financial Results - The Manila Times
ReShape Lifesciences (RSLS) Sets Q3 2024 Earnings Call with Post-Merger Chairman | RSLS Stock News - StockTitan
ReShape secures NIH grant to develop electrodes for diabetes treatment device - Medical Device Network
Health Canada approves ReShape's Lap-Band 2.0 FLEX - Investing.com
ACNB Corporation Receives Regulatory Approvals to Acquire Traditions Bancorp, Inc. - The Manila Times
Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX - GlobeNewswire
ReShape's Lap-Band 2.0 FLEX Secures Health Canada Approval, Expands Market Reach | RSLS Stock News - StockTitan
Next-Generation Diabetes-Managing Innovations - Trend Hunter
Banzai Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement - The Manila Times
ReShape Lifesciences receives NIH supplementary grant with CARSS - TipRanks
ReShape Lifesciences® Receives NIH Supplementary Grant with - GlobeNewswire
ReShape Lifesciences Secures $241K NIH Grant for Breakthrough Diabetes Device Development | RSLS Stock News - StockTitan
Inuvo Reports 23% Sequential Revenue Growth in Q3 2024On November 8, 2024, Inuvo, Inc. (NYSE American: INUV) released its financial performance for the third quarter of 2024, showcasing a substantial 23% sequential revenue increase to $22.4 million c - Defense World
Enphase Energy Inc (ENPH-Q) QuotePress Release - The Globe and Mail
Johnson & Johnson (JNJ-N) QuotePress Release - The Globe and Mail
Brookfield Asset Management Ltd (BAM-N) QuotePress Release - The Globe and Mail
(RSLS) Technical Pivots with Risk Controls - Stock Traders Daily
Qualcomm Inc (QCOM-Q) QuotePress Release - The Globe and Mail
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOI, RS - GuruFocus.com
(RSLS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail
What's Driving These Stocks Higher In After-hours? - RTTNews
Objective long/short (RSLS) Report - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) Stock Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Weight-Loss Devices Market 2024: Global Segmentation Trends, - openPR
ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 472.0% in September - MarketBeat
Implantable Pulse Generator Market Report 2024: Size, Share, Growth, Forecast to 2033 - WhaTech
Gastric Electrical Stimulators Market will attempt to create - openPR
ReShape Lifesciences Enters Into A Merger Agreement With Vyome Therapeutics - MPO-mag
How to Take Advantage of moves in (RSLS) - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
RSLS stock touches 52-week low at $4.99 amid market challenges - Investing.com
Bariatric Surgery Devices Global Market Research 2024-2033: Outlook and Overview - WhaTech
ReShape Lifesciences (OTCMKTS:RSLSD) Trading Up 2.3% - Defense World
Trend Tracker for (RSLS) - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) and Sintx Technologies (NASDAQ:SINT) Head to Head Analysis - Defense World
Gastric Balloon Procedures Market Insights and Growth - openPR
A new trading data show ReShape Lifesciences Inc. (RSLS) is showing positive returns. - SETE News
Finanzdaten der Reshape Lifesciences Inc-Aktie (RSLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):